If you look at Bots own investor presentations on 28/02/23 they say 3.7m axillary actively seeking treatment, and another 7.3m axillary not seeking treatment. They also claim a market size of ~$1.6 billion.
They have a source on the bottom of the page "Source: 1. Doolittle, J. et al. Arch Dermatol Res, 2016. 2. Hamm H. et al. Dermatology. 2006."
if you divide 1.6 billion by 3.7 million you get $432 spent by each person actively seeking treatment.
No idea if that's actually reality, and who's right or wrong.
If you look at Bots own investor presentations on 28/02/23 they...
-
- There are more pages in this discussion • 5,282 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $689.3M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 37.5¢ | $1.784M | 4.691M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 248028 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 356327 | 6 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |